1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsInnovation Bridge Program is sponsored by RI Life Science Hub. The Innovation Bridge Program provides funding to researchers ready to spin out intellectual property and establish a commercial entity, as well as early-stage life science companies and startups needing funding to bridge early developmental gaps.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Innovation Bridge Program | RI Life Science Hub Innovation Bridge Program Eligibility and Evaluation Researchers ready to spin out IP and establish a commercial entity Early-stage life science companies and startups who need funding to bridge early developmental gaps All applicants must be focused on company formation/growth Variable, based on funding request and merit of the application Typical award size: $25,000-$100,000 Direct costs including materials, supplies and equipment associated with establishing a commercial entity/advancing early commercial milestones 30% cap on indirect costs (overhead rates, staff, and rent) Contact us to view the application This in an "Invitation Only" application - please reach out to info@rilifescience.
com to request a code. A thriving life science industry requires key support from those who know the industry, regulations, startup pitfalls, funding landscape and more. Organizations who serve and target underrepresented populations in the life sciences have the potential to shape the Rhode Island life science industry and provide opportunities for all Rhode Islanders.
RILSH is conscientious of duplication, and we ask applicants to conduct a landscape study before applying, to ensure that the applicant’s offering serve a unique and distinct need in the Rhode Island life science industry. Programs well-positioned for funding are those that focus on bridging key gaps, provide equitable access to services and programs, and focus on entities with commercialization/commercial potential.
The Innovation Bridge program is designed to support innovators in the life sciences by providing funding to bridge critical gaps in the technology development lifecycle. This opportunity aims to accelerate the development of cutting-edge solutions by addressing key challenges such as technology validation, regulatory navigation, market readiness, and scaling operations.
Through Innovation Bridge, selected innovators will receive financial support to advance their work toward commercialization, along with access to subject-matter experts, industry networks, and strategic resources. The program seeks to drive innovation, strengthen the life sciences ecosystem, and promote economic growth within Rhode Island.
Eligible applicants include researchers, startups, and early-stage companies developing novel solutions in biotechnology, pharmaceuticals, medical devices, diagnostics, and other life science fields. Funding is intended to support activities that enhance product readiness, de-risk development pathways, and attract additional investment while fostering high-impact innovation in Rhode Island.
According to the current listing, eligibility includes: Researchers ready to spin out IP and establish a commercial entity; Early-stage life science companies and startups who need funding to bridge early developmental gaps. Confirm the full requirements in the official notice before applying.
The current listing shows variable, typical award size: $25,000-$100,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Innovation Bridge Program is funded by RI Life Science Hub. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleNIH published its 'what we heard' summary on the proposed cap on simultaneous Research Project Grants in August 2026. A four-RPG cap would free $1.3 billion for about 1,900 additional investigators; a two-RPG cap would free roughly $3.5 billion for about 5,200. Respondents overwhelmingly proposed alternatives. Here is what the comment record actually says, what NIH signaled about next steps, and how PIs and research offices should position before a policy notice lands.
Read article